Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy

NCT00688194 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

396

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: anastrozole
DRUG: exemestane
DRUG: fulvestrant
DRUG: lapatinib ditosylate
DRUG: letrozole
OTHER: placebo

Sponsor

Gruppo Italiano Mammella (GIM)